Table 1: Characteristics and clinical data of the placebo (R) and intervention (Y) groupsin participants with ADHD1.

1Values are expressed as the mean ± SD.Data from 7 participants with attention deficit hyperactivity disorder (ADHD). *p < 0.05 compared to baseline by pair t-test.† p < 0.05 compared to R by pair t-test.AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; HDL, high density lipoprotein; LDL, low density lipoprotein; WBC, white blood cell; RBC, red blood cell; TIBC, total iron binding capacity; TBARS, thiobarbituric acid reactive substances.
Baseline R Y
Physical measurement
Height (cm) 130.6±13.3 131.6±13.1* 131.4±13.3*
Body weight (kg) 29.9±7.5 30.9±8.2* 31.4±7.1*
Body mass index(kg/m2) 17.4±2.1 17.6±2.2 18.0±1.8*
Liver function
AST (U/L) 28.14±3.18 26.29±1.89 28.57±3.87
ALT (U/L) 15.71±3.25 15.14±2.48 18.71±3.35
Bilirubin-Total (mg/dL) 0.59±0.11 0.49±0.18 0.37±0.14
Kidney function
BUN (mg/dL) 12.69±3.26 12.69±2.98 13.37±3.23
Creatinine (mg/dL) 0.48±0.06 0.49±0.09 0.46±0.07
Uric acid (mg/dL) 4.54±1.12 4.63±1.12 4.06±0.95
Sodium (meq/L) 140.71±1.25 140.29±1.11 139.86±1.35
Potassium (meq/L) 4.53±0.37 4.44±0.26 4.71±0.25
Nutritional status
Albumin (g/dL) 4.76±0.17 4.89±0.25 4.71±0.23
Lipid profile
Triglyceride (mg/dL) 57.86±26.43 59.00±19.74 66.43±36.29
Cholesterol (mg/dL) 171.14±16.43 168.57±29.44 165.00±22.23
HDL-Cholesterol (mg/dL) 59.14±9.48 59.71±14.42 60.14±12.25
LDL- Cholesterol (mg/dL) 100.43±14.74 100.00±23.9 93.57±13.04
Hematology
WBC (10e3/μL) 6.90±2.56 7.20±1.83 7.17±1.44
RBC (10e6/μL) 5.09±0.74 5.01±0.64 5.03±0.76
Hemoglobin (g/dL) 13.50±1.23 13.31±0.95 13.26±1.27
Platelet (10e3/μL) 343.86±44.7 378.14±35.18 367.00±72.94
Iron status
Iron (μg/dL) 118.29±40.49 94.86±16.64 72.00±23.01
TIBC (μg/dL) 374.29±35.95 375.14±37.94 376.14±29.23
Ferritin (ng/mL) 63.33±34.49 48.89±23.77 44.94±23.36
Oxidative stress
TBARS (μM) 2.12±0.54 2.11±0.48 1.80±0.42*†